Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1980 1
1982 2
1983 3
1984 1
1985 2
1987 2
1989 1
1990 6
1991 1
1992 3
1993 7
1994 2
1995 3
1996 3
1997 4
1998 6
1999 5
2000 4
2001 5
2002 2
2003 4
2004 7
2005 6
2006 6
2007 4
2008 9
2009 9
2010 14
2011 9
2012 2
2013 7
2014 8
2015 10
2016 11
2017 13
2018 24
2019 6
2020 15
2021 9
2022 10
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for alone bock
Your search for Alona Bock retrieved no results
Extracorporeal Life Support in Infarct-Related Cardiogenic Shock.
Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, Lehmann R, Eitel I, Graf T, Seidler T, Schuster A, Skurk C, Duerschmied D, Clemmensen P, Hennersdorf M, Fichtlscherer S, Voigt I, Seyfarth M, John S, Ewen S, Linke A, Tigges E, Nordbeck P, Bruch L, Jung C, Franz J, Lauten P, Goslar T, Feistritzer HJ, Pöss J, Kirchhof E, Ouarrak T, Schneider S, Desch S, Freund A; ECLS-SHOCK Investigators. Thiele H, et al. N Engl J Med. 2023 Oct 5;389(14):1286-1297. doi: 10.1056/NEJMoa2307227. Epub 2023 Aug 26. N Engl J Med. 2023. PMID: 37634145 Clinical Trial.
METHODS: In this multicenter trial, patients with acute myocardial infarction complicated by cardiogenic shock for whom early revascularization was planned were randomly assigned to receive early ECLS plus usual medical treatment (ECLS group) or usual medical treatment alone …
METHODS: In this multicenter trial, patients with acute myocardial infarction complicated by cardiogenic shock for whom early revascularizat …
Yoga as a Complementary Therapy for Adults with Type 2 Diabetes: Design and Rationale of the Healthy, Active, and in Control (HA1C) Study.
Thind H, Fava JL, Guthrie KM, Stroud L, Gopalakrishnan G, Sillice M, Gidron N, Bock BC. Thind H, et al. Int J Yoga Therap. 2018 Nov;28(1):123-132. doi: 10.17761/2018-00026. Epub 2018 Aug 21. Int J Yoga Therap. 2018. PMID: 30130144 Free PMC article. Clinical Trial.
Diabetes is the seventh leading cause of death in the United States. For most patients, medication alone is not sufficient to achieve glycemic control; attention must also be paid to multiple healthy behaviors including diet, regular physical activity, and stress managemen …
Diabetes is the seventh leading cause of death in the United States. For most patients, medication alone is not sufficient to achieve …
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L; Gore REDUCE Clinical Study Investigators. Søndergaard L, et al. N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404. N Engl J Med. 2017. PMID: 28902580 Free article. Clinical Trial.
We investigated the effect of PFO closure combined with antiplatelet therapy versus antiplatelet therapy alone on the risks of recurrent stroke and new brain infarctions. METHODS: In this multinational trial involving patients with a PFO who had had a cryptogenic stroke, w …
We investigated the effect of PFO closure combined with antiplatelet therapy versus antiplatelet therapy alone on the risks of recurr …
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
Glechner A, Wagner G, Mitus JW, Teufer B, Klerings I, Böck N, Grillich L, Berzaczy D, Helbich TH, Gartlehner G. Glechner A, et al. Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3. Cochrane Database Syst Rev. 2023. PMID: 36999589 Free PMC article. Review.
OBJECTIVES: To assess the comparative effectiveness and safety of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening for women at average risk of breast cancer. ...False-negative results were less common when ultraso …
OBJECTIVES: To assess the comparative effectiveness and safety of mammography in combination with breast ultrasonography versus mammography …
Chromatin accessibility profiling methods.
Minnoye L, Marinov GK, Krausgruber T, Pan L, Marand AP, Secchia S, Greenleaf WJ, Furlong EEM, Zhao K, Schmitz RJ, Bock C, Aerts S. Minnoye L, et al. Nat Rev Methods Primers. 2021;1:10. doi: 10.1038/s43586-020-00008-9. Epub 2021 Jan 21. Nat Rev Methods Primers. 2021. PMID: 38410680 Free PMC article.
Although chromatin accessibility profiling is invaluable to study gene regulation, alone it provides only a partial view of this complex process. Orthogonal assays facilitate the interpretation of accessible regions with respect to enhancer-promoter proximity, functional t …
Although chromatin accessibility profiling is invaluable to study gene regulation, alone it provides only a partial view of this comp …
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial.
Sidorenkov G, Stadhouders R, Jacobs C, Mohamed Hoesein FAA, Gietema HA, Nackaerts K, Saghir Z, Heuvelmans MA, Donker HC, Aerts JG, Vermeulen R, Uitterlinden A, Lenters V, van Rooij J, Schaefer-Prokop C, Groen HJM, de Jong PA, Cornelissen R, Prokop M, de Bock GH, Vliegenthart R. Sidorenkov G, et al. Eur J Epidemiol. 2023 Apr;38(4):445-454. doi: 10.1007/s10654-023-00975-9. Epub 2023 Mar 21. Eur J Epidemiol. 2023. PMID: 36943671 Free PMC article. Clinical Trial.
We hypothesize that our models will improve the specificity of nodule management by 10% without loss of sensitivity as compared to assessment of nodule size/growth alone, and reduce unnecessary work-up by 40-50%....
We hypothesize that our models will improve the specificity of nodule management by 10% without loss of sensitivity as compared to assessmen …
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.
Germon ZP, Sillar JR, Mannan A, Duchatel RJ, Staudt D, Murray HC, Findlay IJ, Jackson ER, McEwen HP, Douglas AM, McLachlan T, Schjenken JE, Skerrett-Byrne DA, Huang H, Melo-Braga MN, Plank MW, Alvaro F, Chamberlain J, De Iuliis G, Aitken RJ, Nixon B, Wei AH, Enjeti AK, Huang Y, Lock RB, Larsen MR, Lee H, Vaghjiani V, Cain JE, de Bock CE, Verrills NM, Dun MD. Germon ZP, et al. Sci Signal. 2023 Mar 28;16(778):eabp9586. doi: 10.1126/scisignal.abp9586. Epub 2023 Mar 28. Sci Signal. 2023. PMID: 36976863
In mice grafted with FLT3 mutant AML cells, treatment with a NOX2 inhibitor reduced the number of circulating cancer cells, and combining FLT3 and NOX2 inhibitors increased survival to a greater extent than either treatment alone. Together, these data raise the possibility …
In mice grafted with FLT3 mutant AML cells, treatment with a NOX2 inhibitor reduced the number of circulating cancer cells, and combining FL …
Impact of Serial Intralesional Steroid Injections on Idiopathic Subglottic Stenosis.
Hoffman MR, Patro A, Huang LC, Chen SC, Berry LD, Gelbard A, Francis DO; North American Airway Collaborative. Hoffman MR, et al. Laryngoscope. 2023 Sep;133(9):2255-2263. doi: 10.1002/lary.30449. Epub 2022 Oct 26. Laryngoscope. 2023. PMID: 36286239 Clinical Trial.
RESULTS: Two hundred and ninety patients were included, 238 undergoing endoscopic dilation alone and 52 undergoing dilation and SILSI. No differences in baseline characteristics were observed. ...
RESULTS: Two hundred and ninety patients were included, 238 undergoing endoscopic dilation alone and 52 undergoing dilation and SILSI …
Diagnostic quality assessment for low-dimensional ECG representations.
Kovács P, Böck C, Tschoellitsch T, Huemer M, Meier J. Kovács P, et al. Comput Biol Med. 2022 Nov;150:106086. doi: 10.1016/j.compbiomed.2022.106086. Epub 2022 Sep 13. Comput Biol Med. 2022. PMID: 36191392 Free article.
The proposed methodology takes into account that the observers may agree by chance alone. Consequently, for the case study, our statistical analysis reports the "true", beyond-chance agreement in contrast to other, less robust measures, such as simple percent agreement cal …
The proposed methodology takes into account that the observers may agree by chance alone. Consequently, for the case study, our stati …
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP; HIDIT Study Group. Wedemeyer H, et al. N Engl J Med. 2011 Jan 27;364(4):322-31. doi: 10.1056/NEJMoa0912696. N Engl J Med. 2011. PMID: 21268724 Free article. Clinical Trial.
We investigated the safety and efficacy of 48 weeks of treatment with peginterferon alfa-2a plus adefovir dipivoxil, peginterferon alfa-2a alone, and adefovir dipivoxil alone. METHODS: We conducted a randomized trial in which 31 patients with HDV infection received …
We investigated the safety and efficacy of 48 weeks of treatment with peginterferon alfa-2a plus adefovir dipivoxil, peginterferon alfa-2a …
237 results